Ludo Reynders, Ph.D. has been appointed chief executive officer of Premier Research Group Ltd. Dr. Reynders spent the last five years serving as chief executive officer of AAIPharma, Inc., where he transformed the company from a pain-focused specialty pharmaceutical company into a full-service drug development services company. Prior to that, Dr. Reynders spent 16 years with Quintiles Transnational Corp., where he held positions including managing director of PharmaBio Development and chief executive officer of Quintiles Development Services. Dr. Reynders also held several positions with Bristol Myers Corp. in Brussels.

Michael Barry, chairman at Premier Research, said, “We are extremely pleased to have Ludo join us in this critically important role. We are privileged to have someone with Ludo’s reputation and proven track record join Premier Research. His extensive global CRO experience is a perfect fit for our growing organization.”